These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 23574733

  • 1. Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy.
    Rayatzadeh H, Tan A, Chan RH, Patel SJ, Hauser TH, Ngo L, Shaw JL, Hong SN, Zimetbaum P, Buxton AE, Josephson ME, Manning WJ, Nezafat R.
    J Cardiovasc Magn Reson; 2013 Apr 10; 15(1):31. PubMed ID: 23574733
    [Abstract] [Full Text] [Related]

  • 2. Left ventricular scar burden specifies the potential for ventricular arrhythmogenesis: an LGE-CMR study.
    Scott PA, Rosengarten JA, Murday DC, Peebles CR, Harden SP, Curzen NP, Morgan JM.
    J Cardiovasc Electrophysiol; 2013 Apr 10; 24(4):430-6. PubMed ID: 23210601
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R, Chaudhry U, van der Pals J, Engblom H, Arheden H, Heiberg E, Wu KC, Borgquist R, Carlsson M.
    Circ Cardiovasc Imaging; 2017 Sep 10; 10(9):. PubMed ID: 28838961
    [Abstract] [Full Text] [Related]

  • 4. Can QRS scoring predict left ventricular scar and clinical outcomes?
    Rosengarten JA, Scott PA, Chiu OK, Shambrook JS, Curzen NP, Morgan JM.
    Europace; 2013 Jul 10; 15(7):1034-41. PubMed ID: 23493411
    [Abstract] [Full Text] [Related]

  • 5. Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease.
    Alexandre J, Saloux E, Dugué AE, Lebon A, Lemaitre A, Roule V, Labombarda F, Provost N, Gomes S, Scanu P, Milliez P.
    J Cardiovasc Magn Reson; 2013 Jan 19; 15(1):12. PubMed ID: 23331500
    [Abstract] [Full Text] [Related]

  • 6. Complexity of scar and ventricular arrhythmias in dilated cardiomyopathy of any etiology: Long-term data from the SCARFEAR (Cardiovascular Magnetic Resonance Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy Delivery) Registry.
    Pedretti S, Vargiu S, Baroni M, Dellegrottaglie S, Lanzarin B, Roghi A, Milazzo A, Quattrocchi G, Lunati M, Pedrotti P.
    Clin Cardiol; 2018 Apr 19; 41(4):494-501. PubMed ID: 29663442
    [Abstract] [Full Text] [Related]

  • 7. Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death.
    Wu KC, Gerstenblith G, Guallar E, Marine JE, Dalal D, Cheng A, Marbán E, Lima JA, Tomaselli GF, Weiss RG.
    Circ Cardiovasc Imaging; 2012 Mar 19; 5(2):178-86. PubMed ID: 22267750
    [Abstract] [Full Text] [Related]

  • 8. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
    Almehmadi F, Porta-Sánchez A, Ha ACT, Fischer HD, Wang X, Austin PC, Lee DS, Nanthakumar K.
    J Am Heart Assoc; 2017 Aug 19; 6(8):. PubMed ID: 28862957
    [Abstract] [Full Text] [Related]

  • 9. Association of cardiovascular magnetic resonance-derived circumferential strain parameters with the risk of ventricular arrhythmia and all-cause mortality in patients with prior myocardial infarction and primary prevention implantable cardioverter defibrillator.
    Paiman EHM, Androulakis AFA, Shahzad R, Tao Q, Zeppenfeld K, Lamb HJ, van der Geest RJ.
    J Cardiovasc Magn Reson; 2019 May 16; 21(1):28. PubMed ID: 31096987
    [Abstract] [Full Text] [Related]

  • 10. The Occurrence of Implantable Cardioverter Defibrillator Therapies After Generator Replacement in Patients Who No Longer Meet Primary Prevention Indications.
    Kawata H, Hirai T, Doukas D, Hirai R, Steinbrunner J, Wilson J, Noda T, Hsu J, Krummen D, Feld G, Wilber D, Santucci P, Birgersdotter-Green U.
    J Cardiovasc Electrophysiol; 2016 Jun 16; 27(6):724-9. PubMed ID: 26915696
    [Abstract] [Full Text] [Related]

  • 11. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G, Guaricci AI, Andreini D, Solbiati A, Guglielmo M, Mushtaq S, Baggiano A, Beltrama V, Fusini L, Rota C, Segurini C, Conte E, Gripari P, Dello Russo A, Moltrasio M, Tundo F, Lombardi F, Muscogiuri G, Lorenzoni V, Tondo C, Agostoni P, Bartorelli AL, Pepi M.
    Circ Cardiovasc Imaging; 2016 Oct 16; 9(10):. PubMed ID: 27729359
    [Abstract] [Full Text] [Related]

  • 12. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
    Nakhoul GN, Schold JD, Arrigain S, Harb SC, Jolly S, Wilkoff BL, Nally JV, Navaneethan SD.
    Clin J Am Soc Nephrol; 2015 Jul 07; 10(7):1119-27. PubMed ID: 26111859
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.
    Forleo GB, Della Rocca DG, Papavasileiou LP, Panattoni G, Sergi D, Duro L, Mahfouz K, Magliano G, Santini L, Romeo F.
    J Cardiovasc Med (Hagerstown); 2011 Nov 07; 12(11):779-84. PubMed ID: 21941203
    [Abstract] [Full Text] [Related]

  • 14. Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD).
    Cheng A, Zhang Y, Blasco-Colmenares E, Dalal D, Butcher B, Norgard S, Eldadah Z, Ellenbogen KA, Dickfeld T, Spragg DD, Marine JE, Guallar E, Tomaselli GF.
    Circ Arrhythm Electrophysiol; 2014 Dec 07; 7(6):1084-91. PubMed ID: 25273351
    [Abstract] [Full Text] [Related]

  • 15. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
    Muthalaly RG, Kwong RY, John RM, van der Geest RJ, Tao Q, Schaeffer B, Tanigawa S, Nakamura T, Kaneko K, Tedrow UB, Stevenson WG, Epstein LM, Kapur S, Zei PC, Koplan BA.
    JACC Cardiovasc Imaging; 2019 Jul 07; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcomes after primary prevention defibrillator implantation are better predicted when the left ventricular ejection fraction is assessed by cardiovascular magnetic resonance.
    Champ-Rigot L, Gay P, Seita F, Benouda L, Morello R, Pellissier A, Alexandre J, Saloux E, Milliez P.
    J Cardiovasc Magn Reson; 2020 Jun 25; 22(1):48. PubMed ID: 32580786
    [Abstract] [Full Text] [Related]

  • 17. Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description.
    Cheng A, Dalal D, Butcher B, Norgard S, Zhang Y, Dickfeld T, Eldadah ZA, Ellenbogen KA, Guallar E, Tomaselli GF.
    J Am Heart Assoc; 2013 Feb 22; 2(1):e000083. PubMed ID: 23525420
    [Abstract] [Full Text] [Related]

  • 18. Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention.
    Yazaki K, Suzuki A, Shiga T, Minami Y, Arai K, Ashihara K, Shoda M, Hagiwara N.
    BMC Cardiovasc Disord; 2021 Feb 19; 21(1):106. PubMed ID: 33607967
    [Abstract] [Full Text] [Related]

  • 19. Prognostic impact of chronic total coronary occlusion on long-term outcomes in implantable cardioverter-defibrillator recipients with ischaemic heart disease.
    Nishikawa T, Fujino M, Nakajima I, Asaumi Y, Kataoka Y, Anzai T, Kusano K, Noguchi T, Goto Y, Nishimura K, Miyamoto Y, Kiso K, Yasuda S.
    Europace; 2017 Jul 01; 19(7):1153-1162. PubMed ID: 27738062
    [Abstract] [Full Text] [Related]

  • 20. Contemporary rates and outcomes of single- vs. dual-coil implantable cardioverter defibrillator lead implantation: data from the Israeli ICD Registry.
    Leshem E, Suleiman M, Laish-Farkash A, Konstantino Y, Glikson M, Barsheshet A, Goldenberg I, Michowitz Y, Israeli Working Group of Pacing and Electrophysiology.
    Europace; 2017 Sep 01; 19(9):1485-1492. PubMed ID: 27702848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.